Published in Clin Infect Dis on September 01, 1998
Antibiotic-associated diarrhea: candidate organisms other than Clostridium difficile. Korean J Intern Med (2008) 0.81
Enteropathogenic Klebsiella pneumoniae HIV-infected adults, Africa. Emerg Infect Dis (2003) 0.75
Molecular characterization of Klebsiella pneumoniae isolates from stool specimens of outpatients in sentinel hospitals Beijing, China, 2010-2015. Gut Pathog (2017) 0.75
Evidence for clonal spread of a single strain of beta-lactamase-producing Enterococcus (Streptococcus) faecalis to six hospitals in five states. J Infect Dis (1991) 4.82
Cross-resistance to nalidixic acid, trimethoprim, and chloramphenicol associated with alterations in outer membrane proteins of Klebsiella, Enterobacter, and Serratia. J Infect Dis (1985) 4.52
Inducible resistance to vancomycin in Enterococcus faecium D366. J Infect Dis (1989) 4.34
Dissemination of the novel plasmid-mediated beta-lactamase CTX-1, which confers resistance to broad-spectrum cephalosporins, and its inhibition by beta-lactamase inhibitors. Antimicrob Agents Chemother (1988) 3.57
Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg (1998) 2.90
SHV-5, a novel SHV-type beta-lactamase that hydrolyzes broad-spectrum cephalosporins and monobactams. Antimicrob Agents Chemother (1989) 2.60
Susceptibility of Nocardia asteroides to 46 antibiotics, including 22 beta-lactams. Antimicrob Agents Chemother (1983) 2.15
Two distinct types of trimethoprim-resistant dihydrofolate reductase specified by R-plasmids of different compatibility groups. J Biol Chem (1977) 2.13
Reappraisal of distal diagnostic testing in the diagnosis of ICU-acquired pneumonia. Chest (1995) 2.04
Resistance to cefotaxime and seven other beta-lactams in members of the family Enterobacteriaceae: a 3-year survey in France. Antimicrob Agents Chemother (1992) 1.96
Translocation of antibiotic resistance markers of a plasmid-free Streptococcus pyogenes (group A) strain into different streptococcal hemolysin plasmids. Mol Gen Genet (1984) 1.88
Effects of different activity and inactivity paradigms on myosin heavy chain gene expression in striated muscle. J Appl Physiol (1985) (2001) 1.79
Cephalosporinase induction and cephalosporin resistance: a longstanding misinterpretation. Clin Microbiol Infect (2002) 1.74
Carbapenems as inhibitors of OXA-13, a novel, integron-encoded beta-lactamase in Pseudomonas aeruginosa. Microbiology (1998) 1.72
Decreased teicoplanin susceptibility of methicillin-resistant strains of Staphylococcus aureus. J Infect Dis (1995) 1.68
The relationships among IGF-1, DNA content, and protein accumulation during skeletal muscle hypertrophy. J Appl Physiol (1985) (1996) 1.68
Low-level resistance to fluoroquinolones among Salmonella and Shigella. Clin Microbiol Infect (2000) 1.63
Trends in bacterial resistance to fluoroquinolones. Clin Infect Dis (1997) 1.63
Discrepant responses to triple combination antiretroviral therapy in advanced HIV disease. AIDS (1998) 1.62
Nucleotide sequence of the afimbrial-adhesin-encoding afa-3 gene cluster and its translocation via flanking IS1 insertion sequences. J Bacteriol (1994) 1.60
Impaired endothelial nitric oxide synthase activity associated with enhanced caveolin binding in experimental cirrhosis in the rat. Gastroenterology (1999) 1.58
Twenty-year survivors of heart transplantation at Stanford University. Am J Transplant (2008) 1.57
Pain in the well-fixed, aseptic titanium hip replacement. The role of corrosion. J Bone Joint Surg Br (2004) 1.53
Narrow host range of some streptococcal R plasmids. Plasmid (1982) 1.52
Transferable plasmid-mediated antibiotic resistance in Acinetobacter. Plasmid (1983) 1.52
Plasmid-mediated resistance to multiple antibiotics in Salmonella typhi. J Infect Dis (1986) 1.50
Accuracy of radial arterial pressure measurement during surgery under controlled hypotension. Acta Anaesthesiol Scand (2002) 1.48
Effect of clavulanic acid and amoxycillin formulation against beta-lactamase producing Gram-negative bacteria in urinary tract infections. J Antimicrob Chemother (1979) 1.47
Outcome in cardiac recipients of donor hearts with increased left ventricular wall thickness. Am J Transplant (2007) 1.46
Expression of collagen and related growth factors in rat tendon and skeletal muscle in response to specific contraction types. J Physiol (2007) 1.46
European Committee on Antimicrobial Susceptibility Testing (EUCAST) Technical Notes on antimicrobial susceptibility testing. Clin Microbiol Infect (2006) 1.45
Molecular genetics of resistance to macrolides, lincosamides and streptogramin B (MLS) in streptococci. J Antimicrob Chemother (1985) 1.45
ST-elevation myocardial infarction following heart transplantation as an unusual presentation of coronary allograft vasculopathy: a case report. Transplant Proc (2013) 1.44
Detection of Leishmania DNA by polymerase chain reaction in scars of treated human patients. J Infect Dis (1998) 1.44
The afimbrial adhesive sheath encoded by the afa-3 gene cluster of pathogenic Escherichia coli is composed of two adhesins. Mol Microbiol (1996) 1.43
Useful oldies: oral antibiotics for the treatment of MRSA infections. J Hosp Infect (2004) 1.39
In vivo and in vitro emergence of simultaneous resistance to both beta-lactam and aminoglycoside antibiotics in a strain of Serratia marcescens. Ann Microbiol (Paris) (1983) 1.36
Conjugative R plasmids in Streptococcus faecium (group D). Antimicrob Agents Chemother (1982) 1.35
Short-term strength training and the expression of myostatin and IGF-I isoforms in rat muscle and tendon: differential effects of specific contraction types. J Appl Physiol (1985) (2006) 1.33
The changing pattern of trimethoprim resistance in Paris, with a review of worldwide experience. Rev Infect Dis (1986) 1.29
Artificial gravity as a countermeasure to microgravity: a pilot study examining the effects on knee extensor and plantar flexor muscle groups. J Appl Physiol (1985) (2009) 1.26
Microgravity-induced transformations of myosin isoforms and contractile properties of skeletal muscle. J Appl Physiol (1985) (1996) 1.26
High-level chromosomal gentamicin resistance in Streptococcus agalactiae (group B). Antimicrob Agents Chemother (1990) 1.24
A prospective analysis of fenestrated endovascular grafting: intermediate-term outcomes. Eur J Vasc Endovasc Surg (2006) 1.21
Time course of changes in markers of myogenesis in overloaded rat skeletal muscles. J Appl Physiol (1985) (1999) 1.20
Human infections caused by thiamine- or menadione-requiring Staphylococcus aureus. J Clin Microbiol (1978) 1.19
Effect of unloading followed by reloading on expression of collagen and related growth factors in rat tendon and muscle. J Appl Physiol (1985) (2008) 1.16
In-vitro activity of azithromycin against various Gram-negative bacilli and anaerobic bacteria. J Antimicrob Chemother (1990) 1.14
Distribution of drb genes coding for Dr binding adhesins among uropathogenic and fecal Escherichia coli isolates and identification of new subtypes. Infect Immun (1997) 1.11
Synergistic effect of amoxicillin and cefotaxime against Enterococcus faecalis. Antimicrob Agents Chemother (1995) 1.11
[Drug sensitivity of Haemophilus sp. and transfer of resistance into E. coli (author's transl)]. Pathol Biol (Paris) (1977) 1.11
Monitoring plasma levels of ganciclovir in AIDS patients receiving oral ganciclovir as maintenance therapy for CMV retinitis. Clin Microbiol Infect (2000) 1.08
Susceptibility survey of piperacillin alone and in the presence of tazobactam. J Antimicrob Chemother (1993) 1.07
Combined isometric, concentric, and eccentric resistance exercise prevents unloading-induced muscle atrophy in rats. J Appl Physiol (1985) (2007) 1.06
Skeletal muscle growth in young rats is inhibited by chronic exposure to IL-6 but preserved by concurrent voluntary endurance exercise. J Appl Physiol (1985) (2008) 1.06
[Trimethoprim resistance plasmids: transferability and incompatibility groups (author's transl)]. Ann Microbiol (Paris) (1977) 1.05
Detection and characterization of mechanisms of action of aneugenic chemicals. Mutagenesis (2002) 1.05
Sequential occurrence of thyroid autoantibodies and Graves' disease after immune restoration in severely immunocompromised human immunodeficiency virus-1-infected patients. J Clin Endocrinol Metab (2000) 1.04
Vancomycin-resistant Staphylococcus aureus: no apocalypse now. Clin Microbiol Infect (2003) 1.04
Mutation of Salmonella paratyphi A conferring cross-resistance to several groups of antibiotics by decreased permeability and loss of invasiveness. Antimicrob Agents Chemother (1988) 1.03
Mechanism of transferable resistance to chloramphenicol in Haemophilus parainfluenzae. Antimicrob Agents Chemother (1978) 1.03
Transfer of amikacin resistance by closely related plasmids in members of the family Enterobacteriaceae isolated in Chile. Antimicrob Agents Chemother (1986) 1.03
Delayed occurrence of Graves' disease after immune restoration with HAART. Highly active antiretroviral therapy. Lancet (1998) 1.02
OXA-35 is an OXA-10-related beta-lactamase from Pseudomonas aeruginosa. J Antimicrob Chemother (2001) 1.02
Monitoring of vancomycin serum levels for the treatment of staphylococcal infections. Clin Microbiol Infect (2006) 1.01
Molecular cloning and characterization of the afa-7 and afa-8 gene clusters encoding afimbrial adhesins in Escherichia coli strains associated with diarrhea or septicemia in calves. Infect Immun (1999) 1.00
Influence of mechanical loading on myosin heavy-chain protein and mRNA isoform expression. J Appl Physiol (1985) (1996) 0.99
Further doubts over the performance of treatment centres in providing elective orthopaedic surgery. J Bone Joint Surg Br (2009) 0.98
Comparison of Etest with agar dilution for testing the susceptibility of Pseudomonas aeruginosa and other multidrug-resistant bacteria to colistin. J Antimicrob Chemother (2007) 0.98
Relevance of the Alexander Project: pharmacodynamic considerations. J Antimicrob Chemother (1996) 0.98
The relationship between chronic glycaemic control and oxidative stress in type 2 diabetes mellitus. Br J Biomed Sci (2008) 0.97
Mortality of nosocomial pneumonia in ventilated patients: influence of diagnostic tools. Am J Respir Crit Care Med (1996) 0.97
[Plasmidic resistance of "Haemophilus sp." to aminoglycoside antibiotics: isolation and study of a new phosphotransferase (author's transl)]. Ann Microbiol (Paris) (1977) 0.97
Enteroadherent Escherichia coli and diarrhea in children: a prospective case-control study. J Clin Microbiol (1996) 0.97
Consequences of increasing resistance to antimicrobial agents. Clin Infect Dis (1998) 0.96
Effects of spaceflight and thyroid deficiency on rat hindlimb development. II. Expression of MHC isoforms. J Appl Physiol (1985) (2000) 0.96
[Antibiotic resistance genetic basis of human origin streptococci (author's transl)]. Pathol Biol (Paris) (1982) 0.96
Role of denervation in modulating IIb MHC gene expression in response to T(3) plus unloading state. J Appl Physiol (1985) (2000) 0.95
Activities of two new teicoplanin amide derivatives (MDL 62211 and MDL 62873) compared with activities of teicoplanin and vancomycin against 800 recent staphylococcal isolates from France and the United States. Antimicrob Agents Chemother (1991) 0.95
Single- versus triple-lumen central catheter-related sepsis: a prospective randomized study in a critically ill population. Am J Med (1992) 0.94
Cat scratch disease due to Bartonella henselae serotype Marseille (Swiss cat) in a seronegative patient. J Clin Microbiol (1998) 0.94
Resistance pattern of anaerobic bacteria isolated in a general hospital during a two-year period. J Antimicrob Chemother (1981) 0.93
[Increased resistance of streptococcus pneumoniae to antibiotics and prevalence of their capsular serotypes (author's transl)]. Pathol Biol (Paris) (1978) 0.92
Leishmanial antigens in the diagnosis of active lesions and ancient scars of American tegumentary leishmaniasis patients. Mem Inst Oswaldo Cruz (2001) 0.92
Disseminated toxoplasmosis in non-allografted patients with hematologic malignancies: report of two cases and literature review. Eur J Clin Microbiol Infect Dis (2013) 0.92
Genetically related human immunodeficiency virus type 1 in three adults of a family with no identified risk factor for intrafamilial transmission. J Virol (1998) 0.92
High frequency of immature dendritic cells and altered in situ production of interleukin-4 and tumor necrosis factor-alpha in lung cancer. Cancer Immunol Immunother (2008) 0.91
["Pseudomonas aeruginosa" beta-lactamases and sensitivity to carbenicillin (author's transl)]. Ann Microbiol (Paris) (1976) 0.91
Abdominal tuberculosis. Dis Colon Rectum (1988) 0.91
Ischio-vertebral dysplasia: a distinct entity. Pediatr Radiol (1999) 0.90
[Surgical removal of pulmonary metastasis: prospective study in 182 patients]. Rev Assoc Med Bras (1999) 0.90
Transcriptional regulation of the type I myosin heavy chain gene in denervated rat soleus. Am J Physiol Cell Physiol (2002) 0.90
Lymphatic mapping in the treatment of breast cancer. Oncology (Williston Park) (1998) 0.90
Effect of previous antimicrobial therapy on the accuracy of the main procedures used to diagnose nosocomial pneumonia in patients who are using ventilation. Chest (1995) 0.89
Clinical relevance of molecular staging for melanoma: comparison of RT-PCR and immunohistochemistry staining in sentinel lymph nodes of patients with melanoma. Ann Surg (2000) 0.89
In vivo regulation of the beta-myosin heavy chain gene in soleus muscle of suspended and weight-bearing rats. Am J Physiol Cell Physiol (2000) 0.89
[Activity of sulbactam and clavulanic acid, alone and combined, on Acinetobacter calcoaceticus]. Ann Microbiol (Paris) (1983) 0.89
[Scleroderma with anomalies of the thyroid function. 7 cases]. Ann Med Interne (Paris) (1997) 0.89
Use of rifampin for the treatment of serious staphylococcal and gram-negative bacillary infections. Rev Infect Dis (1983) 0.88